Pre-Series A Growth Capital Raise
Advising an Indian fabless semiconductor and AI-enabled mobility technology company on its Pre-Series A fundraising to accelerate product commercialisation and international expansion.
Emani Capital Advisory delivers senior-led M&A advisory, capital raising, and strategic corporate finance solutions across Life Sciences, Deep Tech, and core industrial sectors.
Representative Engagements
Sector Verticals
Global Capital Corridors
Phase Execution Framework
Every mandate is led directly by senior partners, from initial positioning through to final closing negotiations.
Technical fluency across Life Sciences, Deep Tech, and Advanced Industrials translates complex enterprise value into compelling investment cases.
We evaluate every opportunity through a product and technology lens ??? uncovering the technical strengths, commercial viability, and competitive advantages that truly drive value.
Emani Capital Advisory is an independent investment banking firm headquartered in Hyderabad, India, bringing middle-market enterprises, founders, and corporate boards the execution rigor and sector depth typically reserved for large-cap transactions.
Our advisory practice maintains specialized coverage across sectors driven by high technical complexity and capital demand.
Active advisory across Formulations, APIs, CDMO platforms, Biotechnology, Diagnostic Networks, and Medical Consumables.
View Coverage
Coverage across proprietary AI models, Enterprise SaaS, Semiconductors, Industrial IoT, Robotics, Embedded Hardware, and Cyber-Physical Systems.
View Coverage
Advisory for Precision Engineering, OEM Components, Specialty Chemicals, Agrochemical Formulations, and Industrial Gas Distribution.
View Coverage
Coverage across Commercial EV Fleet Infrastructure, Clean Energy Conversion, Last-Mile Logistics Platforms, and B2B Commerce Networks.
View CoverageAdvising an Indian fabless semiconductor and AI-enabled mobility technology company on its Pre-Series A fundraising to accelerate product commercialisation and international expansion.
Advising an integrated healthcare technology and pharmaceutical commerce platform on institutional fundraising to support business expansion and technology scaling.
Advising a pharmaceutical manufacturing company on strategic capital raising to expand manufacturing capacity and strengthen market position.
Illustrative samples presented in compliance with non-disclosure agreements
Defining shareholder objectives, evaluating transaction timing, and establishing baseline valuation expectations.
Constructing institutional three-statement DCF models, and preparing Investment Teasers and Information Memoranda.
Executing confidential, anonymised market outreach to pre-screened strategic acquirers or financial sponsors.
Structuring presentation materials, managing investor Q&A, and moderating strategic management meetings.
Staging Virtual Data Rooms (VDR), managing vendor diligence, and negotiating term sheet mechanics.
Collaborating with legal counsel on SPA/SSA agreements, CP clearances, regulatory filings, and capital settlement.
We combine deep sector domain expertise with cross-border capital market execution to deliver optimal transaction outcomes for growth-stage founders, corporate promoters, and institutional capital providers.
Contact Senior PartnerClients work directly with senior partners at every stage of the transaction process, ensuring experienced judgment and execution stability.
We speak the language of founders and engineers, enabling us to translate complex IP, clinical pipelines, and tech stacks into compelling investment cases.
Proven ability to connect domestic enterprises with strategic buyers and private equity capital across North America, Europe, and Asia.
Our financial models, investment teasers, and virtual data rooms are engineered to meet the stringent standards of global institutional investors.